News and Insights of 3D Printing and Manufacturing
Evonik is expanding its portfolio of 3D printable biomaterials for medical technology: The specialty chemicals company has developed VESTAKEEP iC4800 3DF, a new osteoconductive PEEK filament, for 3D printed implants, that improves fusion between bone and implants. The high-performance polymer can be processed in common extrusion-based 3D printing technologies such as fused filament fabrication (FFF).
CurifyLabs and Natural Machines have entered a strategic partnership to develop a technology that enables customized medicine production through 3D printing – producing personalized medicines for human and veterinary patients, on-site in pharmacies and hospitals. Compounding is the manual preparation of individualized drug treatments for patients where an optimal treatment cannot be achieved with the currently available medicinal products. There are many talented pharmacists who are able to compound drugs manually but the process is ineffective and lacks quality control.
Automated post-processing systems manufacturer Additive Manufacturing Technologies (AMT) has deployed its PostPro chemical vapor smoothing technology to improve the surface finish, comfort, and durability of 3D printed prosthetics.
Pharmaceutical customization technology developer CurifyLabs has partnered with food printing firm Natural Machines with the aim of bringing a new low-cost drug 3D printer to market.
Remember when, in 2017, scientists 3D printed an artificial ovary and implanted it into a sterile mouse, which later gave birth to healthy pups? Now, science has gone one step further by 3D printing testicular cells – showing promising early signs of sperm-producing capabilities.
Researchers from the Technical University of Munich (TUM) and the University of Western Australia are developing 3D printed artificial heart valves made from a patient’s own cells that grow as the individual ages.
Scientists at the University of Texas at Austin’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs have gained US federal backing to create custom additive manufactured birth control devices.
Finland-based bioprinting firm Brinter, together with extrusion technology developer Puredyne, has announced the launch of its new Visco Bio printhead for use with its 3D bioprinters.
The venture capital arm of German chemicals firm Evonik has invested in Nevada-based 3D printed pharmaceutical firm Laxxon Medical to bring the mass production of 3D printed tablets closer to reality.
French 3D printing company Prodways Group achieved a solid end to the year 2021, marked by the good performance of all its activities and major orders for machines and materials. Sustained revenue growth in Q4 (up 17% to €20.2 million) enabled the company to post annual growth of +23.7%, thus exceeding the +20% target communicated last September. Total revenue for the Prodways FY 2021 was €70.8 million, of which €44 million from systems and €26.9 million from services.